tolazamide has been researched along with Hemorrhagic Shock in 1 studies
Tolazamide: A sulphonylurea hypoglycemic agent with actions and uses similar to those of CHLORPROPAMIDE.
tolazamide : An N-sulfonylurea that is 1-tosylurea in which a hydrogen attached to the nitrogen at position 3 is replaced by an azepan-1-yl group. A hypoglycemic agent, it is used for the treatment of type 2 diabetes mellitus.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Hemorrhagic shock is associated with early vasomotor paralysis as well as with early derangements in the intracellular metabolic status." | 1.29 | Inhibition of ATP-activated potassium channels exerts pressor effects and improves survival in a rat model of severe hemorrhagic shock. ( Salzman, AL; Szabó, C, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Szabó, C | 1 |
| Salzman, AL | 1 |
1 other study available for tolazamide and Hemorrhagic Shock
| Article | Year |
|---|---|
Inhibition of ATP-activated potassium channels exerts pressor effects and improves survival in a rat model of severe hemorrhagic shock.
Topics: Animals; ATP-Binding Cassette Transporters; Blood Pressure; Disease Models, Animal; Glyburide; Heart | 1996 |